It takes place over a period of 29 days
Dec 25, 2023 22:48:12 GMT -8
Post by account_disabled on Dec 25, 2023 22:48:12 GMT -8
Salt was administered as a placebo to 451 people, which was administered as an intramuscular injection. two consecutive points Project participants are patients who are infected with COVID-19 who are 18 years and older and have mild to moderate symptoms and show symptoms within a period of not more than 7 days, in a way that does not require hospital admission, which project participants must Receive documents confirming SARS-CoV- 2 infection using molecular testing methods.
Antigen or nucleic acid test from sample Phone Number Data collection through the respiratory system (such as through the mouth, nasal passages, or mucus or saliva), which is a sample of germs collected no more than 3 days before the date of participation in the project Participants must not be: Have you ever received the COVID-19 vaccine on the screening date? Primary efficiency Consisting of symptoms from criticism severe COVID-19 infection or death from any cause.
With project participants being criticized. Follow up until 15 months have passed. Approximately 13% of project participants are aged 65 and over. In addition, 90% of project participants are Congenital diseases and conditions that are at high risk of developing Severe symptoms from COVID-19 infection , including cancer , diabetes , obesity , chronic lung disease or asthma , cardiovascular disease.
Antigen or nucleic acid test from sample Phone Number Data collection through the respiratory system (such as through the mouth, nasal passages, or mucus or saliva), which is a sample of germs collected no more than 3 days before the date of participation in the project Participants must not be: Have you ever received the COVID-19 vaccine on the screening date? Primary efficiency Consisting of symptoms from criticism severe COVID-19 infection or death from any cause.
With project participants being criticized. Follow up until 15 months have passed. Approximately 13% of project participants are aged 65 and over. In addition, 90% of project participants are Congenital diseases and conditions that are at high risk of developing Severe symptoms from COVID-19 infection , including cancer , diabetes , obesity , chronic lung disease or asthma , cardiovascular disease.